These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29207158)

  • 1. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Chen M; Lin M; Wang X
    Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
    Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
    J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
    Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
    Liu Y; Liu R; Yang F; Cheng R; Chen X; Cui S; Gu Y; Sun W; You C; Liu Z; Sun F; Wang Y; Fu Z; Ye C; Zhang C; Li J; Chen X
    Mol Cancer; 2017 Mar; 16(1):53. PubMed ID: 28257633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
    Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
    Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Weng WH; Leung WH; Pang YJ; Hsu HH
    Oncol Rep; 2016 Jan; 35(1):107-16. PubMed ID: 26496897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.
    Huang L; Wen C; Yang X; Lou Q; Wang X; Che J; Chen J; Yang Z; Wu X; Huang M; Lan P; Wang L; Iwamoto A; Wang J; Liu H
    Cell Death Dis; 2018 Feb; 9(3):271. PubMed ID: 29449544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Liu X; Wang Y; Zhao J
    Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras.
    Fang Y; Sun B; Li Z; Chen Z; Xiang J
    Mol Carcinog; 2016 Sep; 55(9):1369-77. PubMed ID: 26333174
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
    Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-19a enhances cell proliferation, migration, and invasiveness through enhancing lymphangiogenesis by targeting thrombospondin-1 in colorectal cancer.
    Yin Q; Wang PP; Peng R; Zhou H
    Biochem Cell Biol; 2019 Dec; 97(6):731-739. PubMed ID: 31199884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
    Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
    Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
    Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
    J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
    Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.